摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

meso-1,2-bis(4-methylphenyl)-1,2-ethanediamine | 50764-59-5

中文名称
——
中文别名
——
英文名称
meso-1,2-bis(4-methylphenyl)-1,2-ethanediamine
英文别名
meso-α,α'-diamino-4.4'-dimethyl-bibenzyl;meso-1,2-Bis-(4-methylphenyl)-aethylendiamin;d,l-1,2-Bis-(4-methylphenyl)-aethylendiamin;(1R,2S)-1,2-Di-p-tolylethane-1,2-diamine;(1R,2S)-1,2-bis(4-methylphenyl)ethane-1,2-diamine
meso-1,2-bis(4-methylphenyl)-1,2-ethanediamine化学式
CAS
50764-59-5
化学式
C16H20N2
mdl
——
分子量
240.348
InChiKey
UQUZLWQGLCLOBD-IYBDPMFKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    113-117 °C
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    52
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2921590090

SDS

SDS:1b5d561d05aef43c24dae17c1702dcc6
查看
Name: Meso-1 2-bis(p-tolyl)ethylenediamine 98% Material Safety Data Sheet
Synonym:
CAS: 50764-59-5
Section 1 - Chemical Product MSDS Name:Meso-1 2-bis(p-tolyl)ethylenediamine 98% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
50764-59-5 meso-1,2-Bis(p-tolyl)ethylenediamine 98% unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under nitrogen.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 50764-59-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 115 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C16H20N2
Molecular Weight: 240.35

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Light sensitive.
Conditions to Avoid:
Incompatible materials, light.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 50764-59-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
meso-1,2-Bis(p-tolyl)ethylenediamine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3263
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3263
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, BASIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3263
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 50764-59-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 50764-59-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 50764-59-5 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A


反应信息

  • 作为反应物:
    描述:
    meso-1,2-bis(4-methylphenyl)-1,2-ethanediamine 生成 (1R,2R)-1,2-Di-p-tolyl-N,N'-bis-[1-p-tolyl-meth-(E)-ylidene]-ethane-1,2-diamine
    参考文献:
    名称:
    Voegtle,F.; Goldschmitt,E., Chemische Berichte, 1976, vol. 109, p. 1 - 40
    摘要:
    DOI:
  • 作为产物:
    描述:
    2-[[(1R,2S)-2-[(2-hydroxyphenyl)methylideneamino]-1,2-bis(4-methylphenyl)ethyl]iminomethyl]phenol 在 硫酸 作用下, 生成 meso-1,2-bis(4-methylphenyl)-1,2-ethanediamine
    参考文献:
    名称:
    Voegtle,F.; Goldschmitt,E., Chemische Berichte, 1976, vol. 109, p. 1 - 40
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Heterocyclic compounds as P2X7 ion channel blockers
    申请人:Shum Patrick
    公开号:US20050026916A1
    公开(公告)日:2005-02-03
    The present invention relates to a novel series of 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives of the formula II: wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , X and Y are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are P2X7 ion channel blockers and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and disease conditions associated with the central nervous system, such as stroke, Alzheimer's disease, etc.
    本发明涉及一种新的4,5-二苯基-2-氨基-4,5-二氢咪唑衍生物系列,其化学式为II: 其中R、R1、R2、R3、R4、R5、X和Y如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是P2X7离子通道阻断剂,因此在作为药用剂方面具有用途,特别是在治疗和/或预防具有炎症成分的各种疾病方面,包括炎症性肠病、类风湿关节炎以及与中枢神经系统相关的疾病状况,如中风、阿尔茨海默病等。
  • Cis-imidazolines
    申请人:Fotouhi Nader
    公开号:US20070167437A1
    公开(公告)日:2007-07-19
    There are provided compounds of the formula I wherein R, V 1 , V 2 and Ring A are described herein. The compounds exhibit anticancer activity.
    提供的化合物具有以下结构式I,其中R、V1、V2和环A如本文所述。这些化合物表现出抗癌活性。
  • DIPHENYL-DIHYDRO-IMIDAZOPYRIDINONES
    申请人:Dominique Romyr
    公开号:US20080255119A1
    公开(公告)日:2008-10-16
    and the pharmaceutically acceptable salts and esters thereof X, R 1 , R 2 , Y 1 and Y 2 are described herein inhibit the interaction of MDM2 protein with a p53-like peptide and hence have anti proliferative activity.
    在这里描述的X、R1、R2、Y1和Y2的药用盐和酯抑制MDM2蛋白与类p53肽的相互作用,因此具有抗增殖活性。
  • HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS
    申请人:SHUM Patrick
    公开号:US20080132550A1
    公开(公告)日:2008-06-05
    The present invention relates to a novel series of 4,5-diphenyl-2-amino-4,5-dihydro-imidazole derivatives of the formula II: wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , X and Y are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are P2X7 ion channel blockers and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and disease conditions associated with the central nervous system, such as stroke, Alzheimer's disease, etc.
    本发明涉及一种新的4,5-二苯基-2-氨基-4,5-二氢咪唑衍生物系列,其化学式为II:其中R、R1、R2、R3、R4、R5、X和Y如本文所定义。本发明还涉及制备这些化合物的方法。本发明的化合物是P2X7离子通道阻滞剂,因此在治疗和/或预防具有炎症成分的多种疾病方面,包括炎症性肠病、类风湿性关节炎以及与中枢神经系统相关的疾病状态,如中风、阿尔茨海默病等方面,具有药物学上的用途。
  • CHIRAL CIS-IMIDAZOLINES
    申请人:Fotouhi Nader
    公开号:US20090143364A1
    公开(公告)日:2009-06-04
    and the pharmaceutically acceptable salts and esters thereof, wherein X 1 , X 2 , X 3 , Y 1 , Y 2 and R are described herein inhibit the interaction of MDM2 protein with a p53-like peptide and hence have anti proliferative activity.
    本文中的药物可接受的盐和酯,其中X1、X2、X3、Y1、Y2和R的描述抑制MDM2蛋白与类p53肽的相互作用,因此具有抗增殖活性。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸